Department of Radiotherapy, JIPMER Achieves International Recognition at ESTRO 2026

The Department of Radiotherapy, JIPMER, is delighted to announce that its research abstract titled "Celecoxib versus Oral Glutamine to Prevent Acute Radiation Mucositis in Head and Neck Cancers – A Double-Blind Randomized Controlled Trial" has been recognized among the Top 5% of all abstracts submitted to ESTRO 2026, one of the world's most prestigious conferences in radiation oncology.

The study was presented at ESTRO 2026, held in Stockholm, Sweden, from 15–19 May 2026, and was authored by Shyama S, Salman Haider, Sivaraman G, Ambedkar Yadala, Ramkumar G, Sandhiya Selvarajan, N. Sreekumaran Nair, Anusuya R, Harish M, and Ananth R